The Pharmaceutical Acquisition Report, Second Edition, 2012

Pharmaceutical M&A transaction data, statistics and valuation multiples

Learn about the transactions that shaped today’s pharmaceutical merger and acquisition market, in The Pharmaceutical Acquisition Report, Second Edition, 2012. This annual report gives you vital details – including deal prices, deal terms, financial performance of acquisition targets, critical valuation figures like price/revenue and price/EBITDA multiples and contact information for key individuals – on all publicly announced pharmaceutical mergers and acquisitions, not just the deals covered by major media.

Easily find essential pharmaceutical transaction data, annual pharmaceutical M&A market statistics and information. The Pharmaceutical Acquisition Report, Second Edition, 2012 includes graphs and charts, rankings of largest deals and most active acquirers, as well as therapeutic areas addressed by targets. This in-depth annual review of pharmaceutical mergers and acquisitions also includes an overview of pharmaceutical M&A activity.

Get all this market intelligence and more:
Deal-by-deal transaction data for every announced pharmaceutical deal
Annual pharmaceutical M&A market activity and trend analysis
All the hard-to-find statistics you need to size up the market today--and tomorrow--including:

    ►Price/revenue ratios
    ►Price/EBITDA ratios



Regular Subscription (PDF). Please call if you are interested in a corporate/group subscription.